drugset / Trial / NCT03112382
Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus
RandomizedParallel-groupSingle-blindScreening
Summary
Study whether SLC30A8 rs13266634 polymorphism is associated with type 2 diabetes mellitus (T2DM) susceptibility in Egyptian patients and study effect of Zn supplementation on glycemic control in patients with type 2 diabetes
Timeline
- Start
- 2015-11
- Primary completion
- 2017-05
- Completion
- 2017-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Zinc Supplement | Unknown | — | — |
| Comparator | Vitamin A | Unknown | — | — |
| Comparator | zinc supplement plus vitamin A and E | Unknown | — | — |